Melissa L Bondy

Stanford Medicine Discovery Professor and Professor of Epidemiology and Population Health

Bio

Dr. Melissa Bondy is the inaugural chair of the Department of Epidemiology and Population Health and the Associate Director for Population Sciences at the Stanford Cancer Institute. Before joining Stanford, she was Associate Director of Cancer Prevention and Population Sciences and section chair of Epidemiology and Population Sciences at Baylor College of Medicine. Her research focus is in genetic and molecular epidemiology and is at the forefront of developing innovative ways to assess the roles of heredity and genetic susceptibility in the etiology of cancer and outcomes, primarily brain and breast cancer. Currently, she leads the largest family study of glioma patients, as well as a study of molecular predictors of outcome for glioma patients. She has a strong interest in health disparities and has a current study to investigate the ethnic differences in glioma. She has been working on studying the health effects of exposure to Hurricane Harvey. She serves on the National Cancer Institute’s (NCI) Board of Scientific Advisors, where she provides direct counsel to the Director of the NCI, and is a member of the External Advisory Board for several NCI-designated cancer centers. In 2018, she received the Visiting Scholar Award from the NCI Division of Cancer Epidemiology and Genetics.

Academic Appointments

Professor, Epidemiology and Population Health
Member, Stanford Cancer Institute

Administrative Appointments

Chair, Department of Epidemiology and Population Health, Stanford University School of Medicine (2019 - Present)
Co-Director, Stanford Center for Population Health Sciences (2019 - Present)
Associate Director, Population Sciences at the Stanford Cancer Institute (2019 - Present)
Professor of Epidemiology, Department of Epidemiology, The University of Texas, School of Public Health (2002 - Present)

Honors & Awards

Visiting Scholar Award, National Cancer Institute Division of Cancer Epidemiology and Genetics (2018)
Michael O’Malley Distinguished Professor Award, University of North Carolina (2020)

Boards, Advisory Committees, Professional Organizations

COVID-19 Clinical Research Review Panel, School of Medicine, Stanford University (2020 - Present)
Respond, Recover, Re-open [R3] Team, School of Medicine, Stanford University (2020 - Present)
School of Medicine’s Executive Committee, Stanford University (2019 - Present)
Stanford Cancer Institute Executive Committee, Stanford University (2019 - Present)
External Advisory Board, UK Markey Cancer Center (2020 - Present)
External Advisory Board, University of Chicago Cancer Center (2020 - Present)
External Advisory Committee, University of Hawaii Cancer Center (2019 - Present)
External Advisory Board, Masonic Cancer Center, University of Minnesota (2018 - Present)
External Advisory Board, University of Mississippi Cancer Center (2017 - Present)
External Scientific Advisory Board, The University of Minnesota Cancer Center Member (2005 - Present)
External Advisor, Successfully Obtain Comprehensive Status (2004 - Present)
Susan G. Komen Scientific Director, Susan G. Komen Share For Cures Study (2019 - Present)
External Advisory Board, Fred Hutchinson Cancer Center (2020 - Present)
External Advisory Board, University of Chicago Cancer Center (2019 - Present)
External Advisory Board, Rutgers Cancer Institute of New Jersey (2019 - Present)
External Advisory Committee, Multi-Ethnic Cohort, University of Hawaii (2018 - Present)
Board of Scientific Advisors, National Cancer Institute (2016 - Present)
TRSS-Glioblastoma Working Group, National Cancer Institute (2018 - Present)
NCI Board of Scientific Advisors, Subcommittee on Global Cancer Research (2014 - Present)
Center Scientific Advisory Board, University of Washington EDGE (2014 - Present)
Advisory Committee, Duke Cancer Institute External Scientific (2011 - Present)
External Advisor, Childhood Cancer Survivors Study - St. Jude Children’s Hospital, Memphis, TN (2009 - Present)
Review Editor, Frontiers in Applied Genetic Epidemiology, Frontiers (2011 - Present)
Honorary Editorial Board, The Application of Clinical Genetics (2008 - Present)
Senior Editor, Cancer Epidemiology, Biomarkers & Prevention (2008 - Present)
Editorial Board, Molecular and Translational Epidemiology (2007 - Present)

Current Research and Scholarly Interests

Principal Investigator, Discovery, Biology and Risk of Inherited Variants in Glioma, 1R01CA217105-01A1, NIH/NCI, 05/01/2018-06/30/2022, MPI (Contact PI)

Principal Investigator, Characterizing Germline and Somatic Alterations by Glioma Subtypes and Clinical Outcome, 1R01CA232754-01, 07/01/2019-06/30/2023, MPI (Contact PI)

Co-Leader (Project), SPORE in Brain Cancer, PI – Fred Lang (Sub with MD Anderson), 2 P50CA127001-11, 09/01/2019-08/31/2023

Co-Investigator, Stanford University Cancer Center, PI – Steve Artandi, P30 CA124435, NCI, 09/15/10-05/31/22

Co-Investigator, Ovarian Cancer Survival in African-American Women, PI, Joellen Schildkraut, R01 CA237318-01A1, NIH/NCI, 07/01/2020-06/31/2025

2022-23 Courses

Epidemiology Research Seminar
EPI 236 (Aut)
History of Epidemiology
EPI 297 (Win)

Independent Studies
- Community Health and Prevention Research Master's Thesis Writing
  CHPR 399 (Win)
- Curricular Practical Training and Internship
  CHPR 290 (Win)
- Directed Reading in Epidemiology
  EPI 299 (Aut, Win, Spr, Sum)
- Graduate Research
  EPI 399 (Aut, Win, Spr, Sum)
- Undergraduate Research
  EPI 199 (Aut, Win, Spr, Sum)

Prior Year Courses

2021-22 Courses

History of Epidemiology
EPI 297 (Win)

Find a doctor

Clinics & Services

Research Resources